1. Ing-Lorenzini K, Desmeules J, Plachta O, et al. Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital. Drug Saf. 2009. 32:775–785.
Article
2. Lim YW, Kim YS. The medical treatment of osteoporosis. J Korean Hip Soc. 2009. 21:211–218.
Article
3. Pearce DH, White LM, Bell RS. Musculoskeletal images. Bilateral insufficiency fracture of the femoral neck. Can J Surg. 2001. 44:11–12.
4. Gurdezi S, Trehan RK, Rickman M. Bilateral undisplaced insufficiency neck of femur fractures associated with short-term steroid use: a case report. J Med Case Rep. 2008. 2:79.
Article
5. Iwamoto J, Takeda T. Insufficiency fracture of the femoral neck during osteoporosis treatment: a case report. J Orthop Sci. 2002. 7:707–712.
Article
6. Kwek EB, Goh SK, Koh JS, et al. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008. 39:224–231.
Article
7. Odvina CV, Zerwekh JE, Rao DS, et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005. 90:1294–1301.
Article
8. Capeci CM, Tejwani NC. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg Am. 2009. 91:2556–2561.
Article
9. Goh SK, Yang KY, Koh JS, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007. 89:349–353.
10. El-Khoury GY, Wehbe MA, Bonfiglio M, et al. Stress fractures of the femoral neck: a scintigraphic sign for early diagnosis. Skeletal Radiol. 1981. 6:271–273.
Article